Submitted:
07 July 2026
Posted:
08 July 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Study Area and Design
2.2. Study Population and Sampling Technique
2.3. Sample Collection and Processing
2.4. Serological Testing
2.5. Questionnaire and Data Collection Variables
2.6. Statistical Analysis
2.7. Ethical Considerations
3. Results
4. Discussion
5. Conclusion
References
- steven, E.; Schmitt, B.; Golovko, A.; Mehdi, E.; Santanu, K. Toxoplasmosis. In Terrestrial Manual, 6th ed.; Barry, O.N., Ed.; OIE Scientific Publications, 2008. [Google Scholar]
- Rosso, F.; Les, J.T.; Agudelo, A. Prevalence of infection with Toxoplasma gondii among pregnant women in Cali, Colombia, South America. Am. J. Trop. Med. Hyg. 2008, 78, 504–508. [Google Scholar] [CrossRef] [PubMed]
- Sevgili, M.C.B.; Nalbantoglu, S.; Vatansever, Z. Determination of seropositivity for Toxoplasma gondii in sheep in Sanliurfa Province, Turkey. J. Vet. Anim. Sci. 2005, 29, 107–111. [Google Scholar]
- Robert-Gangneux, F.; Dardé, M.L. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin. Microbiol. Rev. 2012, 25(2), 264–296. [Google Scholar] [CrossRef] [PubMed]
- Jones, J.L.; Dubey, J.P. Waterborne toxoplasmosis – Recent developments. In Experimental Parasitology; 2010; Volume 124, pp. 10–25. [Google Scholar]
- Lass, A.; et al. Detection of Toxoplasma gondii oocysts in environmental soil samples using molecular methods. Eur. J. Clin. Microbiol. Infect. Dis. 2009, 28(6), 599–605. [Google Scholar] [PubMed]
- Montoya, J.G.; Liesenfeld, O. Toxoplasmosis. Lancet 2004, 363, 1965–1976. [Google Scholar] [CrossRef] [PubMed]
- Jones, J.L.; et al. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am. J. Epidemiol. 2001, 154(4), 357–365. [Google Scholar] [CrossRef] [PubMed]
- Soares, J.A.S.; et al. Achados oculares em crianças com toxoplasmose congênita. Arq. Bras. De Oftalmol. 2011, 74, 255–257. [Google Scholar] [CrossRef]
- Singh, S. Mother to child transmission and diagnosis of Toxoplasma gondii infection during pregnancy. Indian J. Med. Microbiol. 2003, 21(2), 69–76. [Google Scholar] [CrossRef] [PubMed]
- Del Bono, V.; et al. Significance of specific immunoglobulin M in the chronological diagnosis of 38 cases of toxoplasmic lymphadenopathy. J. Clin. Microbiol. 1989, 27, 2133–2135. [Google Scholar] [CrossRef] [PubMed]
- Flegr, J.Z.; Kova, S.; Kodym, P. Induction of parasitic protozoan Toxoplasma gondii 1996, 113, 49–54. [CrossRef]
- Buxton, D. Ovine toxoplasmosis: a review. J. R. Soc. Med. 1990, 83, 509–511. [Google Scholar] [CrossRef] [PubMed]
- Elnahas, A.; et al. Toxoplasmosis in pregnant Sudanese women. Saudi Med. J. 2003, 24(7), 868–870. [Google Scholar] [CrossRef] [PubMed]
- Mohamed, M.Y.; et al. Screening of Toxoplasma gondii antibodies in pregnant and aborted women attending Wad Medani Maternity Teaching Hospital and Um Algura Hospital using Toxo-Latex Agglutination and Electro-Chemiluminescence Immunoassay (ECLIA). Arch. Parasitol. 2017, 1(1), 105. [Google Scholar]
| INVESTIGATED VARIABLE | CATEGORY | NUMBER EXAMINED (N) | IGG POSITIVE N (%) | IGG NEGATIVE N (%) | CHI-SQUARE (χ2) | P-VALUE |
|---|---|---|---|---|---|---|
| MATERNAL AGE | Less than 20 years | 36 | 16 (44.4%) | 20 (55.6%) | 0.147 | 0.989 |
| 21–30 years | 124 | 60 (48.4%) | 64 (51.6%) | |||
| 31–40 years | 116 | 52 (44.8%) | 64 (55.2%) | |||
| More than 40 years | 24 | 12 (50.0%) | 12 (50.0%) | |||
| DIETARY HABITS | Consumes raw/undercooked meat | 168 | 116 (69.0%) | 52 (31.0%) | 77.14 | 0.000* |
| Does not consume raw meat | 132 | 24 (18.2%) | 108 (81.8%) | |||
| GESTATIONAL STAGE | First trimester | 112 | 96 (85.7%) | 16 (14.3%) | 109.30 | 0.000* |
| Second trimester | 68 | 36 (52.9%) | 32 (47.1%) | |||
| Third trimester | 120 | 8 (6.7%) | 112 (93.3%) | |||
| PARITY (NUMBER OF CHILDREN) | Zero | 60 | 24 (44.0%) | 36 (56.0%) | 0.906 | 0.636 |
| One | 56 | 32 (57.1%) | 24 (42.9%) | |||
| More than one | 184 | 84 (45.7%) | 100 (54.3%) | |||
| HISTORY OF MISCARRIAGE | Yes | 136 | 120 (88.2%) | 16 (11.8%) | 138.45 | 0.000* |
| No | 164 | 20 (12.2%) | 144 (87.8%) | |||
| SELF-REPORTED PRIOR INFECTION | Yes | 84 | 84 (100.0%) | 0 (0.0%) | 62.40 | 0.000* |
| No | 216 | 56 (25.9%) | 160 (74.1%) | |||
| CONGENITAL DEFECT IN CHILD | Yes | 88 | 80 (90.9%) | 8 (9.1%) | 68.31 | 0.000* |
| No | 212 | 60 (28.3%) | 152 (71.7%) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).